PharmaShots Weekly Snapshot (July 01 - 05, 2019)
Published: Jul 05, 2019 | Tags: Fresenius Kabi, Voluntary, Recalls, Two Lots, Fluorouracil Injection, Potential, Glass Particulate
2.SDSC and Moores Cancer Center Collaboratively Work with CureMatch to Develop Machine Learning Model for the Diagnosis of Bladder Cancer
Published: Jul 02, 2019 | Tags: SDSC, Moores Cancer Center, CureMatch, Develop, Machine Learning Model, Diagnosis, Bladder Cancer
3. Fraunhofer MEVIS' Experts Develops Intelligent Catheter Navigation System in Germany
Published: Jul 02, 2019 | Tags: Fraunhofer, MEVIS, Experts, Develops, Intelligent Catheter Navigation System, Germany
Published: Jul 04, 2019 | Tags: Grifols, Xembify, 20%, SC, Immunoglobulin, Receives, FDA, Approval, Treatment, Primary Immunodeficiencies
5. SIFI Acquires Laboratoire Gifrer Barbezat's Dacudoses and Novoptine for $6.7M in France
Published: Jul 04, 2019 | Tags: SIFI, Acquires, Gifrer Barbezat, Dacudoses, Novoptine, $6.7M, France
Published: Jul 03, 2019 | Tags: Janssen, Returns, Exclusive Rights, Develop, Commercialize, Hanmi, Antidiabetic Obesity Therapy
7. Nosopharm Signs an Agreement with Evotec to Accelerate the Development of Antibiotics
Published: Jul 03, 2019 | Tags:Nosopharm, Signs, Agreement, Evotec, Accelerate, Development, Antibiotics
Published: Jul 03, 2019 | Tags: Karyopharm, Xpovio, selinexor, Receives, FDA, Accelerated Approval, Relapsed/Refractory, Multiple Myeloma
Published: Jul 03, 2019 | Tags: Alexion, Ultomiris, Ravulizumab, Receives, European Commission, Marketing Authorization, Paroxysmal Nocturnal Hemoglobinuria, Adults
10. Samsung Bioepis and Genentech Settles Patent Dispute of Trastuzumab Biosimilar-Ontruzant
Published: Jul 04, 2019 | Tags: Samsung Bioepis, Genentech, Settles, Patent Dispute, Ontruzant, biosimilar, trastuzumab
11. Asieris Signs a Worldwide Development and Commercialization Agreement with Photocure for Cevira
Published: Jul 02, 2019 | Tags: Asieris, Signs, Worldwide, Development, Commercialization, Agreement, Photocure, Cevira
12. GSK to Initiate P-III ContRAst Studies of Otilimab to Treat Moderate to Severe Rheumatoid Arthritis
Published: Jul 03, 2019 | Tags: GSK, Initiates, Four, P-III, ContRAst Studies, Otilimab, Moderate, Severe, Rheumatoid Arthritis
13.ViiV Healthcare's Dovato (dolutegravir/lamivudine) Receives European Commission Marketing Authorization for HIV-1 Infection in Adults and Adolescents
Published: Jul 03, 2019 | Tags: ViiV Healthcare; Dovato; dolutegravir; lamivudine; Receives; European Commission; Marketing Authorization; HIV-1; Infection
14. Sandoz Launches Generic Gefitinib for Locally Advanced or Metastatic Non-Small Cell Lung Cancer in 13 European Countries
Published: Jul 03, 2019 | Tags: Sandoz, Launches, Generic, Gefitinib, Locally Advanced, Metastatic, Non-Small Cell Lung Cancer, 13, European, Countries
15. Genentech Reports Results of Xofluza (baloxavir marboxil) in P-III MINISTONE-2 Study for Influenza in Children
Published: Jul 02, 2019 | Tags: Genentech, Reports, Results, Xofluza, baloxavir marboxil, P-III, MINISTONE-2, Study, Influenza, Children
16. Varian to Acquire Boston Scientific's Oncology Assets for $90M
Published: Jul 02, 2019 | Tags: Varian, Acquire, Boston Scientific, Oncology, Assets, $90M
17. Foundation Medicine's FoundationOne CDx Receives FDA's Approval as a CDx for Lynparza (olaparib)
Published: Jul 01, 2019 | Tags: Foundation Medicine, FoundationOne CDx, Receives, FDA, Approval, CDx, Lynparza, olaparib
Published: Jul 01, 2019 | Tags: Boehringer Ingelheim, Signs, License Agreement, Yuhan Corporation, Develop, Dual Agonist, Nonalcoholic Steatohepatitis
19. Teva Reports Results of Fremanezumab in P-IIIb FOCUS Study for Migraine in Adults
Published: Jul 02, 2019 | Tags: Teva, Reports, Results, Fremanezumab, P-IIIb, FOCUS, Study, Migraine, Adults
Published: Jul 02, 2019 | Tags: AbbVie, Acquire, Allergan, $63B, Medical Aesthetics, Ophthalmology
Published: Jul 01, 2019 | Tags: Biogen, Reports, Results, Spinraza, nusinersen, P-II, NURTURE, Study, Foundation of Care, Spinal Muscular Atrophy
22.Roche's Tecentriq (atezolizumab) + Abraxane Receives CHMP's Recommendation for its Approval in Europe
Published: June 28, 2019 | Tags: Roche, Tecentriq, atezolizumab, Abraxane, Receives, CHMP, Recommendation, Approval, Europe
Published: Jul 01, 2019 | Tags: Janssen, Imbruvica, ibrutinib, Receives, Positive, CHMP, Recommendation, Expanded Use, Chronic Lymphocytic Leukaemia, Waldenstrom Macroglobulinemia, Europe
Published: Jul 01, 2019 | Tags: AstraZeneca, Forxiga, Fasenra, Prefilled Syringe, Pen, Receive, EU, CHMP, Positive Opinion, CV outcomes, T2D, Asthma
25.Pfizer Reports Results of Revatio (sildenafil citrate) in P-III Study for Persistent Pulmonary Hypertension in the Newborns
Published: Jul 01, 2019 | Tags: Pfizer, Reports, Results, Revatio, sildenafil citrate, P-III, Study, Persistent Pulmonary Hypertension, Newborns